Esketamine Treatment in Melbourne

A new generation of care for individuals who haven’t found relief through traditional antidepressants

What to Expect with Esketamine Treatment

Esketamine is typically delivered in structured phases, beginning with more frequent sessions and gradually reducing based on your response and personalised treatment plan.

Duration and intensity may vary depending on your clinical needs and your psychiatrist’s recommendation.

  • Mode: Nasal spray (Spravato®), self-administered under the supervision of our clinical team
  • Frequency: Typically twice weekly during the initial phase, followed by weekly or fortnightly sessions as part of a maintenance plan
  • Adjunctive Care: Often used in combination with an oral antidepressant, as prescribed by your Psychiatrist

Esketamine is delivered in structured phases, starting more frequently and reducing based on your response.

Safety, Monitoring and Support

Esketamine is administered in a clinical setting under the supervision of specialists to ensure your safety during the treatment process.
  • Supervision and Monitoring: Treatment is provided at our private hospital, Fullarton Clinic, with time allocated after each session for monitoring to support your safety and comfort
  • Aftercare Requirements: You will need to arrange transport home, as driving is not permitted until the following day
  • Inpatient Care: Some individuals receiving Esketamine treatment may also require inpatient care, depending on their clinical needs. This will be determined by your treating psychiatrist

Our team will closely monitor your response throughout treatment, supporting your safety, wellbeing, and overall progress.

Potential Side Effects of Esketamine Treatment

As with any medication, some side effects may occur.

These are typically mild and short lived but may include:

  • Dizziness or light-headedness
  • Nausea
  • Drowsiness or fatigue
  • Increased blood pressure (temporary)
  • Feeling disconnected or dissociated shortly after treatment

These effects usually resolve within a few hours. Patients remain under observation following each treatment session to ensure safety and wellbeing before returning home.

Your treating Psychiatrist will carefully assess your suitability and talk you through potential risks and benefits.

Maintaining Wellness and Safety, With You in Control

Your care doesn’t end after a single phase of treatment — we continue to support your progress with options that respect your needs and preferences.

Esketamine is administered in a calm, private setting within our hospital, providing immediate support if needed. Patients remain under observation for a short period after each session to ensure comfort and safety.

Esketamine is often part of a broader treatment plan, including Inpatient Treatment, Counselling, medications, or Day Programs to support long term wellness. 

At Fullarton Clinic, your care is guided by informed choice. Our team is here to answer your questions, explain all available options, and ensure you feel informed, supported, and respected throughout your treatment.

For a detailed cost breakdown and more information on the process, download our brochure.

Ongoing monitoring and review are part of every Esketamine care plan.

 

Esketamine: Approved Access and Clinical Perspective

Esketamine is a newer class of antidepressant approved by the Therapeutic Goods Administration (TGA) for use in Australia and is becoming increasingly accessible through supported treatment pathways.

“For the first time, we have a Government-funded medicine specifically for people trapped in an acute depressive episode despite treatment with multiple antidepressants.”

— Professor Ian Hickie, Brain and Mind Centre, University of Sydney

 
 

If you’ve struggled to find relief through traditional medications, Esketamine may offer a new path forward. Our team is here to explore your options with care and clinical expertise. Contact us to learn more about the treatment and the admission process.

Frequently Asked Questions about our Esketamine Treatment

Below, we’ve answered some of the most common questions our patients and their families ask. If you’d like to speak to someone directly, our team can discuss your concerns and provide further support.

1Is Esketamine treatment available in Australia??
Yes, Esketamine is administered at selected facilities in Australia. It is a relatively new treatment option for Depression, when other treatments may not have been effective.
2What is the cost of esketamine treatment?
Esketamine treatment costs can vary depending on whether you receive care as an inpatient or outpatient, and your individual treatment plan. Inpatient Treatment Costs For patients with eligible private health insurance that includes psychiatric services, inpatient treatment may involve minimal out-of-pocket costs, excluding pharmacy expenses. Inpatient care provides additional support, including 24/7 nursing care and psychiatrist oversight. Outpatient Treatment Costs Outpatient treatment involves an initial psychiatric assessment, followed by scheduled treatment sessions. Initial assessment: Psychiatrist consultation up to $700 (Medicare rebate approximately $184) plus a $200 hospital fee. Ongoing treatment: Psychiatrist monitoring up to $300 per session (Medicare rebate approximately $134) plus a $200 hospital fee per session. Treatment sessions are typically scheduled twice weekly initially, then weekly, depending on your treatment plan. For a detailed breakdown of esketamine treatment costs, download our brochure. Our team can also explain the expected costs, private health insurance coverage and available options before you commence treatment.
3What is the difference between Ketamine treatment and Esketamine treatment?
Ketamine and Esketamine are closely related medications used to treat depression when other treatments haven't been effective. Ketamine contains two forms of the molecule and may be administered by infusion, injection or other routes in specialist settings. Esketamine (brand name Spravato) contains one of these forms and is administered as a nasal spray. It is approved in Australia for treatment-resistant depression and must be administered in a clinical setting under medical supervision. Both treatments differ in their administration and regulatory approval. Fullarton Clinic offers Esketamine treatment in Melbourne through inpatient and outpatient services.
4Where can I get Esketamine treatment for Depression treatment?
You can receive treatment at our private mental health hospital in Melbourne. Contact our intake team to learn more.
5What is Spravato nasal spray?
Spravato is the brand name for Esketamine nasal spray, a prescription medication used to treat certain forms of depression, including treatment-resistant depression. It is administered under medical supervision as part of a structured treatment program. Esketamine treatment is available in Melbourne at Fullarton Clinic.

Considering Esketamine Treatment?

 

If you would like to learn more about Esketamine treatment at Fullarton Clinic, start by completing the form below. You can also ask your doctor for a referral to Fullarton Clinic in Melbourne.

Please select one
Please select one
Please select one

By submitting this form, you consent to Fullarton Clinic collecting and using your information to respond to your enquiry, in accordance with our Privacy Policy.